U.S. market Closed. Opens in 16 hours 53 minutes

BHVN | Biohaven Pharmaceutical Holding Company Ltd. Stock Financials Income Statements Annual

(Stock Exchange: NYSE)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-31
RevenueN/AN/A462.51MN/AN/AN/AN/AN/AN/A
Cost of Revenue3.37M1.39M91.66M72.00KN/AN/AN/AN/AN/A
Gross Profit-3.37M-1.39M370.85M-72.00KN/AN/AN/AN/AN/A
Operating Expenses432.68M567.93M218.90M114.51M479.12M224.55MN/AN/AN/A
Selling, General & Admin59.40M130.86M37.41M16.05M134.45M34.60MN/A5.11M2.14M
Research & Development373.28M437.07M181.49M98.46M344.67M189.95MN/A55.53M7.56M
Other Operating ExpensesN/A-1.91M1.21MN/AN/AN/AN/A-60.64M-9.70M
Operating Income-436.05M-567.93M-218.90M-114.51M-479.12M-224.55MN/A-60.64M-9.70M
Other Expenses / Income26.50M-1.91M6.47M-4.16M-49.26M-15.90MN/A-2.81M-370.00K
Before Tax Income-409.55M-569.84M-212.43M-118.67M-528.39M-240.46MN/A-63.44M-10.07M
Income Tax Expenses-1.38M438.00K1.37M-134.30K419.00K467.00KN/A90.00KN/A
Net Income-408.17M-570.28M-213.80M-118.67M-528.80M-240.92MN/A-63.68M-10.06M
Interest ExpensesN/A-1.39M-41.55MN/A-12.71M11.76MN/A385.00KN/A
Basic Shares Outstanding71.20M44.74M35.82M35.82M48.49M39.19MN/A14.22M13.09M
Diluted Shares Outstanding71.20M44.74M35.82M35.82M48.49M39.19MN/A14.22M13.09M
EBITDA-432.68M-566.55M-217.51M-114.43M-479.12M-227.51MN/A-63.14M-9.70M
EBITDA Margin0.00%0.00%-47.03%0.00%0.00%0.00%0.00%0.00%0.00%
EBIT-409.55M-571.23M-253.98M-118.80M-541.10M-228.69MN/A-63.20M-10.06M
EBIT Margin0.00%0.00%-54.91%0.00%0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙